Angiographic features and procedures
| JCUH (n = 113) | PCI in SHOCK trial17 (n = 82) | |
|---|---|---|
| GP, glycoprotein; IABP, intra-aortic balloon pump; LAD, left anterior descending coronary artery; LMS, left main stem; RCA, right coronary artery; TIMI, thrombolysis in myocardial infarction. | ||
| Multivessel coronary disease | 89 (79%) | 81% |
| LMS disease >50% | 17 (15%) | 14% |
| Single vessel disease | 24 (21%) | 19% |
| Culprit vessel | ||
| LAD | 58 (51%) | 50% |
| RCA | 33 (29%) | 33% |
| Circumflex | 12 (11%) | 9% |
| LMS | 6 (5.3%) | 5% |
| Unknown | 1 (0.9%) | NA |
| Saphenous vein graft | 3 (2.7%) | 4% |
| Total occlusion in culprit vessel | 94 (83%) | TIMI 0 or 1, 62% |
| Culprit vessel last remaining vessel | 11 (9.7%) | NA |
| Stent(s) | 54 (48%) | 34% |
| IABP | 103 (91%) | 89% |
| Abciximab | 28 (25%) | Gp IIb/IIIa inhibitor, 32% |
| Ventilation | 19 (17%) | 84% |
| Pacing wire | 21 (19%) | NA |
| Inotropic support | 57 (50%) | 100% |
| PCI success | 82 (73%) | 76% |